Literature DB >> 8148699

Immunity to diphtheria in adults in England.

E Miller, M Rush, P Morgan-Capner, D Hutchinson, L Hindle.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8148699      PMCID： PMC2539596          DOI： 10.1136/bmj.308.6928.598b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Prevalence and correlates of diphtheria toxin antibodies among young adults in Israel.

Authors:  D Cohen; E Katzenelson; M Green; R Slepon; H Bercovier; Y Danon
Journal:  J Infect       Date:  1991-09       Impact factor: 6.072

2.  Diphtheria outbreaks in immunized populations.

Authors:  D T Karzon; K M Edwards
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

3.  A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera.

Authors:  M E Melville-Smith; V A Seagroatt; J T Watkins
Journal:  J Biol Stand       Date:  1983-04

4.  Serological immunity to diphtheria in Sweden in 1978 and 1984.

Authors:  B Christenson; M Böttiger
Journal:  Scand J Infect Dis       Date:  1986

5.  Susceptibility to diphtheria in populations vaccinated before and after elimination of indigenous diphtheria in Denmark. A comparative study of antitoxic immunity.

Authors:  O Simonsen; K Kjeldsen; M W Bentzon; I Heron
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1987-12
  5 in total
  8 in total

1.  Diphtheria antitoxin levels in the 14-30-year age group in Italy.

Authors:  I Mastroeni; A M Patti; A L Santi; N Vescia; S Bocchini; S Bagnod; C Ciapetti; G M Fara
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

Review 2.  The new threats of Gram positive pathogens: re-emergence of things past.

Authors:  R A Howe; N M Brown; R C Spencer
Journal:  J Clin Pathol       Date:  1996-06       Impact factor: 3.411

3.  Diphtheria immunity in Flanders.

Authors:  C Matheï; P Van Damme; P Bruynseels; H Goossens; R Vranckx; A Meheus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

Review 4.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

5.  Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS (®)) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT Polio (®)) given as a booster dose at 6 years of age.

Authors:  Vincent Gajdos; Benoit Soubeyrand; Emmanuel Vidor; Patrick Richard; Julie Boyer; Christine Sadorge; Anne Fiquet
Journal:  Hum Vaccin       Date:  2011-05-01

Review 6.  Diphtheria: are we ready for it?

Authors:  N Begg; V Balraj
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

7.  Evaluation of the safety and pharmacokinetic profile of a new, pasteurized, human tetanus immunoglobulin administered as sham, postexposure prophylaxis of tetanus.

Authors:  R Forrat; R Dumas; M Seiberling; M Merz; C Lutsch; J Lang
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

8.  Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine.

Authors:  Paul Balmer; Ray Borrow; Jamie Findlow; Rosalind Warrington; Sarah Frankland; Pauline Waight; Robert George; Nick Andrews; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2007-09-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.